Soros Fund Management’s BioAmber Inc. BIOA.WS Stock Holding History

Soros Fund Management’s Portfolio BIOA.WS Stock Details BIOA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-194,000	Closed	-$8K	–	350
2017 Q1	$8K	Hold	194,000	–	–	﹤0.01%	260
2016 Q4	$136K	Hold	194,000	–	–	﹤0.01%	203
2016 Q3	$92K	Hold	194,000	–	–	﹤0.01%	220
2016 Q2	$70K	Hold	194,000	–	–	﹤0.01%	171
2016 Q1	$351K	Hold	194,000	–	–	0.01%	187
2015 Q4	$274K	Hold	194,000	–	–	﹤0.01%	234
2015 Q3	$345K	Hold	194,000	–	–	0.01%	213
2015 Q2	$372K	Hold	194,000	–	–	﹤0.01%	227
2015 Q1	$308K	Hold	194,000	–	–	﹤0.01%	221
2014 Q4	$307K	Hold	194,000	–	–	﹤0.01%	183
2014 Q3	$475K	Hold	194,000	–	–	﹤0.01%	258
2014 Q2	$497K	Hold	194,000	–	–	﹤0.01%	273
2014 Q1	$413K	Hold	194,000	–	–	﹤0.01%	279
2013 Q4	$142K	Hold	194,000	–	–	﹤0.01%	235
2013 Q3	$155K	Hold	194,000	–	–	﹤0.01%	231
2013 Q2	$107K	Buy	+194,000	New	+$123K	﹤0.01%	204

Soros Fund Management's BIOA.WS Position: Q2 2017 in Review

Soros Fund Management sold out of BioAmber Inc. (BIOA.WS) in Q2 2017, closing a stake of 194,000 shares — an estimated $8K sold.

Soros Fund Management first reported a position in BIOA.WS in Q2 2013 and held it in 16 quarters. The position peaked at $497K in Q2 2014. 0 funds tracked by Wall St. Rank hold BIOA.WS as of Q2 2017.

Soros Fund Management reported no remaining BioAmber Inc. position as of Q2 2017 after selling out during the quarter.
Soros Fund Management sold 194,000 BioAmber Inc. shares in Q2 2017, an estimated $8K.
Soros Fund Management first reported a position in BioAmber Inc. in Q2 2013 and held it in 16 quarters.
Soros Fund Management's BioAmber Inc. position peaked at $497K in Q2 2014.
0 funds tracked by Wall St. Rank held BioAmber Inc. as of Q2 2017.

Based on Soros Fund Management's 13F filing for Q2 2017, filed 14 Aug 2017.